Jason Pleimann, MD
Foot and Ankle Surgery · Fayetteville, ARNPI 1144293630
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (46.2%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Vilex LLC accounts for 77.8% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2024 at $16,229 and has fallen 50.8% since, to $7,977 in 2025.
Across 139 payments — averaging $274.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vilex LLC$30K
- Stryker$3K
- Arthrex$2K
- Midsouth Orthopedics Inc.$1K
- Novastep Inc.$1K
- Johnson & Johnson$412
- plus $726 from 10 others
What the payments were for
- Consulting fees$17,61846%
- Travel & lodging$16,07342%
- Food & beverage$3,0398%
- Education$1,2403%
- Gifts$1460%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vilex LLC | 40 | $29,661 |
| Stryker(2 entities) | 33 | $3,053 |
| Arthrex | 5 | $1,759 |
| Midsouth Orthopedics Inc. | 6 | $1,427 |
| Novastep Inc. | 5 | $1,078 |
| Johnson & Johnson | 34 | $412 |
| Crossroads Extremity Systems, LLC | 3 | $188 |
| BD | 1 | $120 |
| Innovation Technologies Inc | 2 | $103 |
| Pacira Therapeutics, Inc. | 3 | $75 |
| Exactech, Inc. | 1 | $71 |
| Medline Industries LP | 1 | $58 |
| Smith+Nephew | 1 | $42 |
| Amgen(2 entities) | 2 | $26 |
| AbbVie | 1 | $24 |
| Bioventus LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ALPHALOK Ankle Fusion - R&D$11,419
- ALPHALOK$7,389
- HINTERMANN$5,651
- Ankle Fusion - R&D$2,319
- MIS Distal Bunion - R&D$2,250
- INBONE$1,063
- PECAPLASTY$907
- INFINITY$604
- MIS Instrumentation$201
- INFINITY ADAPTIS$153
- CARTIVA$146
- TFN ADVANCED$121
How this compares
$38,116 in reported general payments places this provider in the 85th percentile of 35 foot and ankle surgery providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 90 | $1,036 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 42 | $346 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in Fayetteville
- Aaron TeufelFayetteville$4K
- Gregory ArdoinLittle Rock$101K
- Frederick DaySpringdale$83K
- Tyler McKeeFort Smith$64K
- Kenneth SeiterFort Smith$46K
- Derrick HenryLittle Rock$18K
- Robert MartinLittle Rock$8K
- Spencer MortensenFort Smith$7K
- Zane MooreConway$5K
- Michael HaugheyJonesboro$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.